Epilepsy Research
Volume 31, Issue 3 , Pages 175-186 , August 1998

Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague–Dawley rats

Received 23 February 1998 ,Revised 23 April 1998 ,Accepted 27 April 1998.

References 

  1. Albertson T, Peterson S, Stark L. Effects of phenobarbital and SC-13504 on partially kindled seizures in rats. Exp. Neurol. 1978;61:270–280
  2. Albertson TE, Peterson SL, Stark LG. The anticonvulsant effects of diazepam and phenobarbital in prekindled and kindled seizures in rats. Neuropharmacology. 1981;20:597–603
  3. Albright PS. Effects of carbamazepine, clonazepam, and phenytoin on seizure threshold in amygdala and cortex. Exp. Neurol. 1983;79:11–17
  4. Bolwig, T.G., Trimble, M.R., 1989. The Clinical Relevance of Kindling. John Wiley & Sons, Chichester.
  5. Cain, D.P., 1986. The transfer phenomenon in kindling. In: Wada, J.A. (Ed.), Kindling 3. Raven Press, New York, pp. 231–248.
  6. Callaghan DA, Schwark WS. Pharmacological modification of amygdaloid-kindled seizures. Neuropharmacology. 1980;19:1131–1136
  7. DeLorenzo, R.J., 1995. Phenytoin. Mechanisms of action. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs, 4th ed. Raven Press, New York, pp. 271–282.
  8. Ebert U, Cramer S, Löscher W. Phenytoin's effect on the spread of seizure activity in the amygdala kindling model. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997;356:341–347
  9. Freeman FG, Jarvis MF. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res. Bull. 1981;7:629–633
  10. Frey H-H, Löscher W, Reiche R, Schultz D. Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites. Pharmacology. 1984;28:329–335
  11. Heinemann U, Draguhn A, Ficker E, Stabel J, Zhang CL. Strategies for the development of drugs for pharmacoresistant epilepsies. Epilepsia. 1994;35(Suppl. 5):S10–S21
  12. Hönack D, Löscher W. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia. 1995;36:763–771
  13. Hvidberg, E.F., 1985. Monitoring antiepileptic drug levels. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs. Springer, Berlin, pp. 725–764.
  14. Johannessen, S.I., Gram, L., Sillanpää, M., Tomson, T., 1995. Intractable Epilepsy. Wrightson Biomedical Publishing Ltd., Petersfield.
  15. Jones, G.L., Wimbish, G.H., 1985. Hydantoins. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs. Springer, Berlin, pp. 351–420.
  16. Jurna, I., 1985. Electrophysiological effects of antiepileptic drugs. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs. Springer, Berlin, pp. 611–658.
  17. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia. 1986;27:706–710
  18. Levy LL, Fenichel GM. Diphenylhydantoin activated seizures. Neurology. 1965;15:716–722
  19. Löscher W. Basic aspects of epilepsy. Curr. Opin. Neurol. Neurosurg. 1993;6:223–232
  20. Löscher W. Animal models of intractable epilepsy. Prog. Neurobiol. 1997;53:239–258
  21. Löscher W. New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol. 1998;342:1–13
  22. Löscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 1988;2:145–181
  23. Löscher W, Hönack D. High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 1990;341:476–481
  24. Löscher W, Hönack D. Responses to NMDA receptor antagonists altered by epileptogenesis. Trends Pharmacol. Sci. 1991;12:52
  25. Löscher W, Rundfeldt C. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats. J. Pharmacol. Exp. Ther. 1991;258:483–489
  26. Löscher W, Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?. Epilepsy Res. 1994;17:95–134
  27. Löscher W, Jäckel R, Czuczwar SJ. Is amygdala kindling in rats a model for drug-resistant partial epilepsy?. Exp. Neurol. 1986;93:211–226
  28. Löscher W, Hönack D, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models. Epilepsy Res. 1991;8:171–189
  29. Löscher W, Rundfeldt C, Hönack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res. 1993;15:207–219
  30. McNamara JO. Pursuit of the mechanisms of kindling. Trends Neurosci. 1988;11:33–36
  31. McNamara JO. Cellular and molecular basis of epilepsy. J. Neurosci. 1994;14:3413–3425
  32. McNamara JO, Rigsbee LC, Butler LS, Shin C. Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann. Neurol. 1989;26:675–678
  33. Oscorio I, Burnstine TH, Remler B, Manon-Espaillat R, Reed RC. Phenytoin-induced seizures: a paradoxical effect at toxic concentrations in epileptic patients. Epilepsia. 1989;30:230–234
  34. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
  35. Racine RJ. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972;32:281–294
  36. Racine RJ, Livingston K, Joaquin A. Effects of procaine hydrochloride, diazepam, and diphenylhydantoin on seizure development in cortical and subcortical structures in rats. Electroencephalogr. Clin. Neurophysiol. 1975;38:355–365
  37. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 1990;42:223–286
  38. Rundfeldt C, Hönack D, Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology. 1990;29:845–851
  39. Sato M, Racine RJ, McIntyre DC. Kindling: basic mechanisms and clinical validity. Electroencephalogr. Clin. Neurophysiol. 1990;76:459–472
  40. Schmidt, D., Morselli, P., 1986. Intractable Epilepsy: Experimental and Clinical Aspects. Raven Press, New York, NY.
  41. Schmidt D, Einicke I, Haenel F. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine. Arch. Neurol. 1986;43:263–265
  42. Wauquier A, Ashton D, Melis W. Behavioural analysis of amygdaloid kindling in Beagle dogs and the effects of clonazepam, diazepam, phenobarbital, diphenylhydantoin, and flunarizine on seizure manifestations. Exp. Neurol. 1979;64:579–586
  43. White HS, Chen CF, Kemp JW, Woodbury DM. Effects of acute and chronic phenytoin on the electrolyte content and the activities of Na+, K+, Ca2+, Mg2+, and HCO3−-ATPases and carbonic anhydrase of neonatal and adult cerebral cortex. Epilepsia. 1985;26:43–57

PII: S0920-1211(98)00029-1

Epilepsy Research
Volume 31, Issue 3 , Pages 175-186 , August 1998

Article Tools

* Image Usage & Resolution